IN8bio (INAB) Revenue & Revenue Breakdown
IN8bio Revenue Highlights
00
IN8bio Revenue by Period
IN8bio Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | - |
IN8bio Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | 100.00% |
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $3.75M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | - |
IN8bio Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
WVE | Wave Life Sciences | $113.31M | $19.69M |
CUE | Cue Biopharma | $5.49M | $3.34M |
TFFP | TFF Pharmaceuticals | $733.87K | $193.39K |
PALI | Palisade Bio | $250.00K | - |
ANIX | Anixa Biosciences | $210.00K | - |
GANX | Gain Therapeutics | $55.18K | - |
RVPH | Reviva Pharmaceuticals | - | - |
CNSP | CNS Pharmaceuticals | - | - |
ZURA | Zura Bio | - | - |
INAB | IN8bio | - | - |
ANNX | Annexon | - | - |
PYPD | PolyPid | - | - |
LTRN | Lantern Pharma | - | - |
ALLR | Allarity Therapeutics | - | - |
WINT | Windtree Therapeutics | - | - |
INMB | INmune Bio | $-155.00K | - |